nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—SLCO1A2—Chlorambucil—testicular cancer	0.303	0.334	CbGbCtD
Tolbutamide—CYP2C18—Ifosfamide—testicular cancer	0.286	0.316	CbGbCtD
Tolbutamide—CYP2C8—Ifosfamide—testicular cancer	0.0687	0.0757	CbGbCtD
Tolbutamide—CYP2C19—Ifosfamide—testicular cancer	0.0576	0.0635	CbGbCtD
Tolbutamide—SLCO1A2—Methotrexate—testicular cancer	0.0543	0.0599	CbGbCtD
Tolbutamide—CYP2C9—Ifosfamide—testicular cancer	0.0479	0.0528	CbGbCtD
Tolbutamide—SLC22A6—Methotrexate—testicular cancer	0.0329	0.0363	CbGbCtD
Tolbutamide—CYP2C8—Etoposide—testicular cancer	0.0328	0.0362	CbGbCtD
Tolbutamide—CYP2C9—Cisplatin—testicular cancer	0.0233	0.0257	CbGbCtD
Tolbutamide—Inappropriate antidiuretic hormone secretion—Chlorambucil—testicular cancer	0.00463	0.0498	CcSEcCtD
Tolbutamide—Inappropriate antidiuretic hormone secretion—Vinblastine—testicular cancer	0.00424	0.0456	CcSEcCtD
Tolbutamide—Digestion impaired—Chlorambucil—testicular cancer	0.00402	0.0433	CcSEcCtD
Tolbutamide—Eruption—Dactinomycin—testicular cancer	0.00316	0.034	CcSEcCtD
Tolbutamide—Inappropriate antidiuretic hormone secretion—Ifosfamide—testicular cancer	0.00306	0.0329	CcSEcCtD
Tolbutamide—Inappropriate antidiuretic hormone secretion—Cisplatin—testicular cancer	0.00264	0.0284	CcSEcCtD
Tolbutamide—Reaction gastrointestinal—Methotrexate—testicular cancer	0.00252	0.0271	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Chlorambucil—testicular cancer	0.00216	0.0233	CcSEcCtD
Tolbutamide—Aplastic anaemia—Dactinomycin—testicular cancer	0.00182	0.0196	CcSEcCtD
Tolbutamide—Pancytopenia—Chlorambucil—testicular cancer	0.0016	0.0172	CcSEcCtD
Tolbutamide—Pancytopenia—Vinblastine—testicular cancer	0.00147	0.0158	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Ifosfamide—testicular cancer	0.00143	0.0154	CcSEcCtD
Tolbutamide—Eruption—Methotrexate—testicular cancer	0.00137	0.0147	CcSEcCtD
Tolbutamide—Agranulocytosis—Vinblastine—testicular cancer	0.00129	0.0138	CcSEcCtD
Tolbutamide—Eruption—Epirubicin—testicular cancer	0.00128	0.0138	CcSEcCtD
Tolbutamide—Pancytopenia—Bleomycin—testicular cancer	0.00124	0.0133	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Cisplatin—testicular cancer	0.00123	0.0133	CcSEcCtD
Tolbutamide—Eruption—Doxorubicin—testicular cancer	0.00118	0.0127	CcSEcCtD
Tolbutamide—Pancytopenia—Dactinomycin—testicular cancer	0.00116	0.0124	CcSEcCtD
Tolbutamide—Hyponatraemia—Cisplatin—testicular cancer	0.00112	0.012	CcSEcCtD
Tolbutamide—Pancytopenia—Ifosfamide—testicular cancer	0.00106	0.0114	CcSEcCtD
Tolbutamide—Leukopenia—Chlorambucil—testicular cancer	0.00105	0.0113	CcSEcCtD
Tolbutamide—Agranulocytosis—Dactinomycin—testicular cancer	0.00101	0.0109	CcSEcCtD
Tolbutamide—Leukopenia—Vinblastine—testicular cancer	0.000965	0.0104	CcSEcCtD
Tolbutamide—Thrombocytopenia—Chlorambucil—testicular cancer	0.00094	0.0101	CcSEcCtD
Tolbutamide—Agranulocytosis—Ifosfamide—testicular cancer	0.000929	0.00999	CcSEcCtD
Tolbutamide—Pancytopenia—Cisplatin—testicular cancer	0.000914	0.00983	CcSEcCtD
Tolbutamide—Erythema—Bleomycin—testicular cancer	0.00091	0.00979	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Epirubicin—testicular cancer	0.000897	0.00964	CcSEcCtD
Tolbutamide—Thrombocytopenia—Vinblastine—testicular cancer	0.000861	0.00926	CcSEcCtD
Tolbutamide—Erythema—Dactinomycin—testicular cancer	0.000849	0.00913	CcSEcCtD
Tolbutamide—Dyspepsia—Chlorambucil—testicular cancer	0.000845	0.00909	CcSEcCtD
Tolbutamide—Pancytopenia—Etoposide—testicular cancer	0.000837	0.00901	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Doxorubicin—testicular cancer	0.00083	0.00892	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.000829	0.00891	CcSEcCtD
Tolbutamide—Leukopenia—Bleomycin—testicular cancer	0.000815	0.00876	CcSEcCtD
Tolbutamide—Aplastic anaemia—Methotrexate—testicular cancer	0.00079	0.0085	CcSEcCtD
Tolbutamide—Erythema—Ifosfamide—testicular cancer	0.000778	0.00837	CcSEcCtD
Tolbutamide—Urticaria—Chlorambucil—testicular cancer	0.000762	0.0082	CcSEcCtD
Tolbutamide—Leukopenia—Dactinomycin—testicular cancer	0.00076	0.00817	CcSEcCtD
Tolbutamide—Aplastic anaemia—Epirubicin—testicular cancer	0.00074	0.00795	CcSEcCtD
Tolbutamide—Agranulocytosis—Etoposide—testicular cancer	0.000734	0.00789	CcSEcCtD
Tolbutamide—Thrombocytopenia—Bleomycin—testicular cancer	0.000727	0.00782	CcSEcCtD
Tolbutamide—Leukopenia—Ifosfamide—testicular cancer	0.000696	0.00749	CcSEcCtD
Tolbutamide—Aplastic anaemia—Doxorubicin—testicular cancer	0.000684	0.00736	CcSEcCtD
Tolbutamide—Pruritus—Chlorambucil—testicular cancer	0.000679	0.0073	CcSEcCtD
Tolbutamide—Thrombocytopenia—Dactinomycin—testicular cancer	0.000678	0.0073	CcSEcCtD
Tolbutamide—Erythema—Cisplatin—testicular cancer	0.000671	0.00721	CcSEcCtD
Tolbutamide—Thrombocytopenia—Ifosfamide—testicular cancer	0.000622	0.00669	CcSEcCtD
Tolbutamide—Leukopenia—Cisplatin—testicular cancer	0.0006	0.00646	CcSEcCtD
Tolbutamide—Urticaria—Bleomycin—testicular cancer	0.00059	0.00635	CcSEcCtD
Tolbutamide—Hypoglycaemia—Epirubicin—testicular cancer	0.000586	0.0063	CcSEcCtD
Tolbutamide—Hyponatraemia—Epirubicin—testicular cancer	0.000574	0.00618	CcSEcCtD
Tolbutamide—Nausea—Chlorambucil—testicular cancer	0.00057	0.00613	CcSEcCtD
Tolbutamide—Headache—Vinblastine—testicular cancer	0.000551	0.00593	CcSEcCtD
Tolbutamide—Leukopenia—Etoposide—testicular cancer	0.00055	0.00591	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000548	0.00589	CcSEcCtD
Tolbutamide—Hypoglycaemia—Doxorubicin—testicular cancer	0.000542	0.00583	CcSEcCtD
Tolbutamide—Thrombocytopenia—Cisplatin—testicular cancer	0.000536	0.00576	CcSEcCtD
Tolbutamide—Hyponatraemia—Doxorubicin—testicular cancer	0.000531	0.00571	CcSEcCtD
Tolbutamide—Pruritus—Bleomycin—testicular cancer	0.000526	0.00565	CcSEcCtD
Tolbutamide—Nausea—Vinblastine—testicular cancer	0.000522	0.00562	CcSEcCtD
Tolbutamide—Urticaria—Ifosfamide—testicular cancer	0.000504	0.00542	CcSEcCtD
Tolbutamide—Pancytopenia—Methotrexate—testicular cancer	0.000502	0.00539	CcSEcCtD
Tolbutamide—Abdominal distension—Epirubicin—testicular cancer	0.000498	0.00535	CcSEcCtD
Tolbutamide—Thrombocytopenia—Etoposide—testicular cancer	0.000491	0.00528	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Methotrexate—testicular cancer	0.000482	0.00518	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000472	0.00508	CcSEcCtD
Tolbutamide—Pancytopenia—Epirubicin—testicular cancer	0.000469	0.00505	CcSEcCtD
Tolbutamide—Rash—Bleomycin—testicular cancer	0.000468	0.00504	CcSEcCtD
Tolbutamide—Abdominal distension—Doxorubicin—testicular cancer	0.00046	0.00495	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Epirubicin—testicular cancer	0.000451	0.00485	CcSEcCtD
Tolbutamide—Pruritus—Ifosfamide—testicular cancer	0.000449	0.00483	CcSEcCtD
Tolbutamide—Nausea—Bleomycin—testicular cancer	0.000441	0.00475	CcSEcCtD
Tolbutamide—Agranulocytosis—Methotrexate—testicular cancer	0.000439	0.00473	CcSEcCtD
Tolbutamide—Rash—Dactinomycin—testicular cancer	0.000437	0.0047	CcSEcCtD
Tolbutamide—Pancytopenia—Doxorubicin—testicular cancer	0.000434	0.00467	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Etoposide—testicular cancer	0.000433	0.00466	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000417	0.00449	CcSEcCtD
Tolbutamide—Nausea—Dactinomycin—testicular cancer	0.000411	0.00443	CcSEcCtD
Tolbutamide—Agranulocytosis—Epirubicin—testicular cancer	0.000411	0.00442	CcSEcCtD
Tolbutamide—Rash—Ifosfamide—testicular cancer	0.0004	0.00431	CcSEcCtD
Tolbutamide—Urticaria—Etoposide—testicular cancer	0.000398	0.00428	CcSEcCtD
Tolbutamide—Agranulocytosis—Doxorubicin—testicular cancer	0.00038	0.00409	CcSEcCtD
Tolbutamide—Nausea—Ifosfamide—testicular cancer	0.000377	0.00406	CcSEcCtD
Tolbutamide—Erythema—Methotrexate—testicular cancer	0.000368	0.00396	CcSEcCtD
Tolbutamide—Pruritus—Etoposide—testicular cancer	0.000355	0.00382	CcSEcCtD
Tolbutamide—Rash—Cisplatin—testicular cancer	0.000345	0.00371	CcSEcCtD
Tolbutamide—Erythema—Epirubicin—testicular cancer	0.000344	0.0037	CcSEcCtD
Tolbutamide—Leukopenia—Methotrexate—testicular cancer	0.000329	0.00354	CcSEcCtD
Tolbutamide—Nausea—Cisplatin—testicular cancer	0.000325	0.0035	CcSEcCtD
Tolbutamide—Erythema—Doxorubicin—testicular cancer	0.000319	0.00343	CcSEcCtD
Tolbutamide—Rash—Etoposide—testicular cancer	0.000316	0.0034	CcSEcCtD
Tolbutamide—Headache—Etoposide—testicular cancer	0.000314	0.00338	CcSEcCtD
Tolbutamide—Leukopenia—Epirubicin—testicular cancer	0.000308	0.00332	CcSEcCtD
Tolbutamide—Nausea—Etoposide—testicular cancer	0.000298	0.0032	CcSEcCtD
Tolbutamide—Thrombocytopenia—Methotrexate—testicular cancer	0.000294	0.00316	CcSEcCtD
Tolbutamide—Leukopenia—Doxorubicin—testicular cancer	0.000285	0.00307	CcSEcCtD
Tolbutamide—Thrombocytopenia—Epirubicin—testicular cancer	0.000275	0.00296	CcSEcCtD
Tolbutamide—Dyspepsia—Methotrexate—testicular cancer	0.000264	0.00284	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000259	0.00279	CcSEcCtD
Tolbutamide—Thrombocytopenia—Doxorubicin—testicular cancer	0.000255	0.00274	CcSEcCtD
Tolbutamide—Dyspepsia—Epirubicin—testicular cancer	0.000247	0.00266	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000243	0.00261	CcSEcCtD
Tolbutamide—Urticaria—Methotrexate—testicular cancer	0.000239	0.00257	CcSEcCtD
Tolbutamide—Dyspepsia—Doxorubicin—testicular cancer	0.000229	0.00246	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000225	0.00241	CcSEcCtD
Tolbutamide—Urticaria—Epirubicin—testicular cancer	0.000223	0.0024	CcSEcCtD
Tolbutamide—Pruritus—Methotrexate—testicular cancer	0.000212	0.00229	CcSEcCtD
Tolbutamide—Urticaria—Doxorubicin—testicular cancer	0.000207	0.00222	CcSEcCtD
Tolbutamide—Pruritus—Epirubicin—testicular cancer	0.000199	0.00214	CcSEcCtD
Tolbutamide—Rash—Methotrexate—testicular cancer	0.000189	0.00204	CcSEcCtD
Tolbutamide—Headache—Methotrexate—testicular cancer	0.000188	0.00202	CcSEcCtD
Tolbutamide—Pruritus—Doxorubicin—testicular cancer	0.000184	0.00198	CcSEcCtD
Tolbutamide—Nausea—Methotrexate—testicular cancer	0.000178	0.00192	CcSEcCtD
Tolbutamide—Rash—Epirubicin—testicular cancer	0.000177	0.00191	CcSEcCtD
Tolbutamide—Headache—Epirubicin—testicular cancer	0.000176	0.00189	CcSEcCtD
Tolbutamide—Nausea—Epirubicin—testicular cancer	0.000167	0.0018	CcSEcCtD
Tolbutamide—Rash—Doxorubicin—testicular cancer	0.000164	0.00176	CcSEcCtD
Tolbutamide—Headache—Doxorubicin—testicular cancer	0.000163	0.00175	CcSEcCtD
Tolbutamide—Nausea—Doxorubicin—testicular cancer	0.000154	0.00166	CcSEcCtD
